, insuline, qui pourraient donc être restaurées par une supplémentation en mélatonine(140)

C. Chan-chee, V. Bayon, J. Bloch, F. Beck, J. Giordanella et al., Épidémiologie de l'insomnie en France : état des lieux, Rev DÉpidémiologie Santé Publique. 1 déc, vol.59, issue.6, pp.409-431, 2011.

, Etat des lieux de la consommation des benzodiazépines -Point d'Information -ANSM : Agence nationale de sécurité du médicament et des produits de santé

D. Sur,

J. Giordanella and . Rapport, Ministère de la Santé et des Solidarités, décembre, 2006.

. Avis, Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail relatif aux risques liés à la consommation de compléments alimentaires contenant de la mélatonine

C. Pr and D. Schröder, Mélatonine : les indications et comment la prescrire. Atelier petit-déjeuner de la SFRMS. Congrès du Sommeil (compte rendu oral en attente de publication), 2018.

C. Ménard and . Mélatonine, agonistes mélatoninergiques et luminothérapie dans les troubles du sommeil et du décalage horaire, 2011.

N. Zisapel, New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation, Br J Pharmacol. 10 janv, 2018.

A. Maras, C. M. Schroder, B. A. Malow, R. L. Findling, J. Breddy et al., Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder, J Child Adolesc Psychopharmacol, vol.28, issue.10, pp.699-710, 2018.

A. G. Wade, M. Farmer, G. Harari, N. Fund, M. Laudon et al., Add-on prolongedrelease melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial, Clin Interv Aging, vol.9, pp.947-61, 2014.

J. Liu, S. J. Clough, A. J. Hutchinson, E. B. Adamah-biassi, M. Popovska-gorevski et al., MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective, Annu Rev Pharmacol Toxicol, vol.56, pp.361-83, 2016.

P. Lemoine and N. Zisapel, Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia, Expert Opin Pharmacother. avr, vol.13, issue.6, pp.895-905, 2012.

Z. Xie, F. Chen, W. A. Li, X. Geng, C. Li et al., A review of sleep disorders and melatonin, Neurol Res. 3 juin, vol.39, issue.6, pp.559-65, 2017.

F. Auld, E. L. Maschauer, I. Morrison, D. J. Skene, and R. L. Riha, Sftg -Has. Prise en charge du patient adulte se plaignant d'insomnie en médecine générale, Médecine Sommeil. déc, vol.34, issue.14, pp.5-27, 2007.

, FC de sommeil C de P. Physiologie du sommeil normal : Troubles du sommeil, Physiol Sommeil Norm Troubl Sommeil, 2007.

M. Vecchierini and . Le, John Libbey Eurotext, vol.176, 1997.

W. B. Webb and H. W. Agnew, Sleep stage characteristics of long and short sleepers, Science. 3 avr, vol.168, issue.3927, pp.146-153, 1970.

, Les examens du sommeil

R. Morphée, Prise en charge de l'insomnie : le cas clinique de Madame T

, Disponible sur

S. Site-du-centre-santé and . Grenoble,

. Isca, , 2012.

, Le sommeil et ses troubles, 2017.

D. Sur, Les troubles du sommeil -Le cycle veille-sommeil

D. Sur, Troubles du sommeil de l'enfant et de l'adulte

, Urry E, Landolt H-P. Adenosine, Caffeine, and Performance: From Cognitive Neuroscience of Sleep to Sleep Pharmacogenetics, Meerlo P, Benca RM, Abel T, éditeurs. Sleep, Neuronal Plasticity and Brain Function, 2016.

H. Berlin, , pp.331-66, 2014.

H. Landolt, J. V. Rétey, K. Tönz, J. M. Gottselig, R. Khatami et al., Caffeine Attenuates Waking and Sleep Electroencephalographic Markers of Sleep Homeostasis in Humans, Neuropsychopharmacology, vol.29, issue.10, 2004.

D. Dijk, V. Schantz, and M. , Prise en charge de l'insomnie -9782294753053 | Elsevier Masson -Livres, ebooks, revues et traités EMC pour toutes spécialités médicales et paramédicales, J Biol Rhythms. août, vol.20, issue.4, pp.279-90, 2005.

J. S. Takahashi, F. W. Turek, R. Y. Moore, and É. C. Clocks,

U. S. Springer,

, Disponible sur, Handbooks of Behavioral Neurobiology), 2001.

J. A. Mong and D. M. Cusmano, Sex differences in sleep: impact of biological sex and sex steroids, 20150110. 35. Hommes et femmes : à chacun son horloge?, vol.371, 1688.

. Salle-de-presse-|-inserm, , 2011.

D. Sur,

A. Lim, A. J. Myers, L. Yu, A. S. Buchman, J. F. Duffy et al., Sex difference in daily rhythms of clock gene expression in the aged human cerebral cortex, J Biol Rhythms. avr, vol.28, issue.2, pp.117-146, 2013.

I. Iglowstein, O. G. Jenni, L. Molinari, and R. H. Largo, Sleep duration from infancy to adolescence: reference values and generational trends, Pediatrics. févr, vol.111, issue.2, pp.302-309, 2003.

, INSV Institut National du Sommeil et de la Vigilance

D. Sur,

, La somnolence des adolescents

. Kantar, , 2013.

M. A. Carskadon, Sleep in adolescents: the perfect storm, Pediatr Clin North Am. juin, vol.58, issue.3, pp.637-684, 2011.

Y. Touitou, D. Touitou, and A. Reinberg, Disruption of adolescents' circadian clock: The vicious circle of media use, exposure to light at night, sleep loss and risk behaviors, J Physiol Paris, vol.110, issue.4, pp.467-79, 2016.

G. S. Richardson, M. A. Carskadon, E. J. Orav, and W. C. Dement, Circadian variation of sleep tendency in elderly and young adult subjects, Sleep, vol.5, issue.2, pp.82-94, 1982.

F. Beck, J. Richard, and D. Léger, Insomnia and total sleep time in France: prevalence and associated socio-demographic factors in a general population survey

, Rev Neurol (Paris). déc, vol.169, issue.12, pp.956-64, 2013.

. Sftg--has, Prise en charge du patient adulte se plaignant d'insomnie en médecine générale, Médecine Sommeil. déc, vol.4, issue.14, pp.5-27, 2007.

-. Atelier-de-chronobiologie-clinique, , 2011.

D. Sur,

S. Anfray,

D. Sur,

, Disponible sur

R. Marx, E. E. Tanner-smith, C. M. Davison, L. Ufholz, J. Freeman et al., Later school start times for supporting the education, health, and well-being of high school students, Cochrane Database Syst Rev, vol.03, p.9467, 2017.

R. R. Auger, H. J. Burgess, J. S. Emens, L. V. Deriy, S. M. Thomas et al., Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD), J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med, vol.11, issue.10, pp.1199-236, 2015.

. Melatonin, 54. null D modification. Melatonin. Pineal Gland Hormone. Regulator of Diurnal Rhythms, Wikipédia [Internet, 2019.

D. Sur,

B. Claustrat, Mélatonine et troubles du rythme veille-sommeil, Médecine Sommeil. janv, vol.6, issue.1, pp.12-24, 2009.

D. P. Cardinali, H. J. Lynch, and R. J. Wurtman, Binding of melatonin to human and rat plasma proteins. Endocrinology, vol.91, pp.1213-1221, 1972.

D. Morin, N. Simon, P. Deprés-brummer, F. Lévi, J. P. Tillement et al., Melatonin highaffinity binding to alpha-1-acid glycoprotein in human serum, Pharmacology. mai, vol.54, issue.5, pp.271-276, 1997.

B. Claustrat, J. Brun, and G. Chazot, The basic physiology and pathophysiology of melatonin, Sleep Med Rev. févr, vol.9, issue.1, pp.11-24, 2005.

D. Acuña-castroviejo, G. Escames, C. Venegas, M. E. Díaz-casado, E. Lima-cabello et al., Extrapineal melatonin: sources, regulation, and potential functions, Cell Mol Life Sci CMLS. août, vol.71, issue.16, pp.2997-3025, 2014.

M. Singh and H. R. Jadhav, Melatonin: functions and ligands, Drug Discov Today. sept, vol.19, issue.9, pp.1410-1418, 2014.

X. Vidal--mélatonine-;-ma, J. R. Idle, K. W. Krausz, and F. J. Gonzalez, Metabolism of melatonin by human cytochromes p450, Disponible sur, vol.33, pp.489-94, 2005.

N. G. Harpsøe, L. Andersen, I. Gögenur, and J. Rosenberg, Clinical pharmacokinetics of melatonin: a systematic review, Eur J Clin Pharmacol. août, vol.71, issue.8, pp.901-910, 2015.

D. Mélatonine and . Gard, , 1977.

D. Sur,

J. Arendt, Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology, Rev Reprod. janv, vol.3, issue.1, pp.13-22, 1998.

. Unithèque,

D. Sur,

M. Challamel, C. R. Lévi, F. Laumon, B. Testu, F. Touitou et al., Rythmes de l'enfant: de l'horloge biologique aux rythmes scolaires, p.141
URL : https://hal.archives-ouvertes.fr/hal-01571640

I. Haimov, M. Laudon, N. Zisapel, M. Souroujon, D. Nof et al., Glutamatergic clock output stimulates melatonin synthesis at night, Eur J Neurosci. janv, vol.309, issue.6948, pp.318-342, 1994.

M. Møller and F. Baeres, The anatomy and innervation of the mammalian pineal gland, Cell Tissue Res. juill, vol.309, issue.1, pp.139-50, 2002.

P. Pévet, Melatonin and biological rhythms, Biol Signals Recept. août, vol.9, issue.3-4, pp.203-215, 2000.

L. J. Lorenz, J. C. Hall, and M. Rosbash, Expression of a Drosophila mRNA is under circadian clock control during pupation, Dev Camb Engl. déc, vol.107, issue.4, pp.869-80, 1989.

S. N. Archer, D. L. Robilliard, D. J. Skene, M. Smits, A. Williams et al., A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference, Sleep. 15 juin, vol.26, issue.4, pp.413-418, 2003.

K. L. Toh, C. R. Jones, Y. He, E. J. Eide, W. A. Hinz et al., An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome, Science. 9 févr, vol.291, issue.5506, pp.1040-1043, 2001.

S. Minegishi, I. Sagami, S. Negi, K. Kano, and H. Kitagishi, Circadian clock disruption by selective removal of endogenous carbon monoxide, Sci Rep. 10 août, vol.8, issue.1, p.11996, 2018.

W. J. Drijfhout, A. G. Van-der-linde, J. B. De-vries, C. J. Grol, and B. H. Westerink, Microdialysis reveals dynamics of coupling between noradrenaline release and melatonin secretion in conscious rats, Neurosci Lett. 5 janv, vol.202, issue.3, pp.185-193, 1996.

A. J. Lewy, T. A. Wehr, F. K. Goodwin, D. A. Newsome, and S. P. Markey, Light suppresses melatonin secretion in humans, Science. 12 déc, vol.210, issue.4475, pp.1267-1276, 1980.

D. Leger, A. Metlaine, C. Gronfier, and L. Et, Consensus Chronobiologie et sommeil de la Société française de recherche et médecine du sommeil (SFRMS). CONSENSUS CHRONOBIOLOGIE 2018. Presse Medicale Paris Fr, déc, vol.47, pp.964-972, 1983.

G. C. Brainard, J. P. Hanifin, J. M. Greeson, B. Byrne, G. Glickman et al., Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor, J Neurosci Off J Soc Neurosci. 15 août, vol.21, issue.16, pp.6405-6417, 2001.

M. Hatori, C. Gronfier, R. N. Van-gelder, P. S. Bernstein, J. Carreras et al., Global rise of potential health hazards caused by blue light-induced circadian disruption in modern aging societies, NPJ Aging Mech Dis, vol.3, p.9, 2017.

B. Claustrat, Mélatonine et troubles du rythme veille-sommeil

D. Sur,

A. Chang, D. Aeschbach, J. F. Duffy, and C. A. Czeisler, Evening use of light-emitting eReaders negatively affects sleep, circadian timing, and next-morning alertness, Proc Natl Acad Sci U S A. 27 janv, vol.112, issue.4, pp.1232-1239, 2015.

C. A. Czeisler, T. L. Shanahan, E. B. Klerman, H. Martens, D. J. Brotman et al.,

, Suppression of melatonin secretion in some blind patients by exposure to bright light, N Engl J Med. 5 janv, vol.332, issue.1, pp.6-11, 1995.

A. L. Gomes-domingos, H. Hermsdorff, and J. Bressan, Melatonin intake and potential chronobiological effects on human health, Crit Rev Food Sci Nutr, vol.59, issue.1, pp.133-173, 2019.

P. J. Murphy, P. Badia, B. L. Myers, M. R. Boecker, and K. P. Wright, Nonsteroidal antiinflammatory drugs affect normal sleep patterns in humans, Physiol Behav. juin, vol.55, issue.6, pp.1063-1069, 1994.

D. P. Cardinali, M. N. Rita, E. Pereyra, and C. G. Solveyra, Role of prostaglandins in rat pineal neuroeffector junction. Changes in melatonin and norepinephrine release in vitro, Endocrinology. août, vol.111, issue.2, pp.530-534, 1982.

K. Brismar, B. Hylander, K. Eliasson, S. Rössner, and L. Wetterberg, Melatonin secretion related to side-effects of beta-blockers from the central nervous system, Acta Med Scand, vol.223, issue.6, pp.525-555, 1988.

F. Scheer, C. J. Morris, J. I. Garcia, C. Smales, E. E. Kelly et al., Repeated melatonin supplementation improves sleep in hypertensive patients treated with betablockers: a randomized controlled trial, Sleep, vol.35, issue.10, pp.1395-402, 2012.

P. Lusardi, E. Piazza, and R. Fogari, Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study, Br J Clin Pharmacol. mai, vol.49, issue.5, pp.423-430, 2000.

Z. Y. Zhao, S. Martin, M. Touitou, and Y. ,

, Simonneaux V, Ribelayga C. Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters, Pharmacol Rev. juin, vol.44, issue.3, pp.325-95, 1996.

G. Hajak, A. Rodenbeck, B. Bandelow, S. Friedrichs, G. Huether et al., Nocturnal plasma melatonin levels after flunitrazepam administration in healthy subjects, Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. mai, vol.6, issue.2, pp.149-53, 1996.

P. A. Childs, I. Rodin, N. J. Martin, N. H. Allen, L. Plaskett et al., Effect of fluoxetine on melatonin in patients with seasonal affective disorder and matched controls, Br J Psychiatry J Ment Sci. févr, vol.166, issue.2, pp.196-204, 1995.

K. P. Wright, P. Badia, B. L. Myers, S. C. Plenzler, and M. Hakel, Caffeine and light effects on nighttime melatonin and temperature levels in sleep-deprived humans, Brain Res. 30 janv, vol.747, issue.1, pp.78-84, 1997.

C. Ursing, J. Wikner, K. Brismar, and S. Röjdmark, Caffeine raises the serum melatonin level in healthy subjects: an indication of melatonin metabolism by cytochrome P450(CYP)1A2, J Endocrinol Invest. mai, vol.26, issue.5, pp.403-409, 2003.

T. Danel and Y. Touitou, Alcohol, chronobiology and sleep

, Pathol Biol (Paris), vol.49, issue.9, pp.726-757, 2001.

J. Wikner, D. E. Andersson, L. Wetterberg, and S. Röjdmark, Impaired melatonin secretion in patients with Wernicke-Korsakoff syndrome, J Intern Med. juin, vol.237, issue.6, pp.571-576, 1995.

F. Congrès-;-fraschini, R. J. Reiter, and B. Stankov, The pineal glands and its hormones: fundamentals and clinical perspectives, p.233, 1995.

B. Guardiola-lemaitre, Melatoninergic receptor agonists and antagonists: therapeutic perspectives

, J Soc Biol, vol.201, issue.1, pp.105-118, 2007.

C. Ekmekcioglu, Melatonin receptors in humans: biological role and clinical relevance, Biomed Pharmacother Biomedecine Pharmacother. avr, vol.60, issue.3, pp.97-108, 2006.

M. L. Dubocovich, P. Delagrange, D. N. Krause, D. Sugden, D. P. Cardinali et al., International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors, Pharmacol Rev. sept, vol.62, issue.3, pp.343-80, 2010.

E. Savaskan, M. A. Ayoub, R. Ravid, D. Angeloni, F. Fraschini et al., Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease, J Pineal Res. janv, vol.38, issue.1, pp.10-16, 2005.

S. Comai and G. Gobbi, Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology, J Psychiatry Neurosci JPN. janv, vol.39, issue.1, pp.6-21, 2014.

O. Nosjean, M. Ferro, F. Coge, P. Beauverger, J. M. Henlin et al., Identification of the melatonin-binding site MT3 as the quinone reductase 2, J Biol Chem, vol.275, issue.40, pp.31311-31318, 2000.

S. R. Pandi-perumal, A. S. Bahammam, N. I. Ojike, O. A. Akinseye, T. Kendzerska et al., Melatonin and Human Cardiovascular Disease, J Cardiovasc Pharmacol Ther. mars, vol.22, issue.2, pp.122-154, 2017.

A. Martínez-Águila, B. Fonseca, P. De-lara, M. J. Pintor, and J. , Effect of Melatonin and 5-Methoxycarbonylamino-N-Acetyltryptamine on the Intraocular Pressure of Normal and Glaucomatous Mice, J Pharmacol Exp Ther. mai, vol.357, issue.2, pp.293-302, 2016.

B. Claustrat, J. Leston, and . Melatonin, Physiological effects in humans, Neurochirurgie. juin, vol.61, issue.2-3, pp.77-84, 2015.

A. Wirz, -. , S. M. Armstrong, A. Wirz-justice, and S. M. Armstrong, Melationin: Nature's Soporific?, J Sleep Res, vol.5, issue.2, pp.137-178, 1996.

D. J. Dijk, C. Roth, H. P. Landolt, E. Werth, M. Aeppli et al., Melatonin effect on daytime sleep in men: suppression of EEG low frequency activity and enhancement of spindle frequency activity, Neurosci Lett. 1 déc, vol.201, issue.1, pp.13-19, 1995.

C. J. Van-den-heuvel, S. A. Ferguson, M. M. Macchi, and D. Dawson, Melatonin as a hypnotic: con, Sleep Med Rev. févr, vol.9, issue.1, pp.71-80, 2005.

E. Ferracioli-oda, A. Qawasmi, and M. H. Bloch, Meta-analysis: melatonin for the treatment of primary sleep disorders, PloS One, vol.8, issue.5, p.63773, 2013.

A. Brzezinski, M. G. Vangel, R. J. Wurtman, N. G. Zhdanova, I. Ben-shushan et al., Effects of exogenous melatonin on sleep: a meta-analysis, Sleep Med Rev. févr, vol.9, issue.1, pp.41-50, 2005.

N. Buscemi, B. Vandermeer, R. Pandya, N. Hooton, L. Tjosvold et al., Melatonin for treatment of sleep disorders, Evid Rep Technol Assess (Summ), issue.108, pp.1-7, 2004.

A. G. Wade, I. Ford, G. Crawford, A. D. Mcmahon, T. Nir et al., Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes, Curr Med Res Opin, vol.23, issue.10, pp.2597-605, 2007.

P. Lemoine, T. Nir, M. Laudon, and N. Zisapel, Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects, J Sleep Res. déc, vol.16, issue.4, pp.372-80, 2007.

R. Luthringer, M. Muzet, N. Zisapel, and L. Staner, The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia, Int Clin Psychopharmacol. sept, vol.24, issue.5, pp.239-288, 2009.

M. Quera-salva and B. Claustrat, Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin®) in insomnia

, L'Encephale. déc, vol.44, issue.6, pp.548-57, 2018.

R. J. Strassman, C. R. Qualls, E. J. Lisansky, and G. T. Peake, Elevated rectal temperature produced by all-night bright light is reversed by melatonin infusion in men, J Appl Physiol Bethesda Md, vol.71, issue.6, pp.2178-82, 1985.

A. Galano, D. Tan, and R. J. Reiter, Melatonin: A Versatile Protector against Oxidative DNA Damage, Mol Basel Switz. 27 févr, vol.23, issue.3, 2018.

R. J. Reiter, J. C. Mayo, D. Tan, R. M. Sainz, A. et al., Melatonin as an antioxidant: under promises but over delivers, J Pineal Res, vol.61, issue.3, pp.253-78, 2016.

M. Basile, C. Romeo, E. Gitto, L. Spitz, A. Pierro et al., Melatonin protects from, but does not reverse, the effects of mediators of sepsis on liver bioenergetics, Pediatr Surg Int. avr, vol.20, issue.4, pp.263-269, 2004.

R. J. Reiter, S. Rosales-corral, D. X. Tan, M. J. Jou, A. Galano et al., Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas, Cell Mol Life Sci CMLS, vol.74, issue.21, pp.3863-81, 2017.

W. Ren, G. Liu, S. Chen, J. Yin, J. Wang et al., Melatonin signaling in T cells: Functions and applications, J Pineal Res. avr, vol.62, issue.3, 2017.

M. F. Farez, I. D. Mascanfroni, S. P. Méndez-huergo, A. Yeste, G. Murugaiyan et al., Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses, Cell. 10 sept, vol.162, issue.6, pp.1338-52, 2015.

S. Cos, R. Fernández, A. Güézmes, and E. J. Sánchez-barceló, Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells, Cancer Res, vol.58, issue.19, pp.4383-90, 1998.

S. Proietti, A. Catizone, M. G. Masiello, S. Dinicola, G. Fabrizi et al., Increase in motility and invasiveness of MCF7 cancer cells induced by nicotine is abolished by melatonin through inhibition of ERK phosphorylation, J Pineal Res. mai, vol.64, issue.4, p.12467, 2018.

Y. Li, S. Li, Y. Zhou, X. Meng, J. Zhang et al., Melatonin for the prevention and treatment of cancer, Oncotarget. 13 juin, vol.8, issue.24, pp.39896-921, 2017.

S. Su, M. Hsieh, Y. , C. Reiter, R. J. Yang et al., Cancer metastasis: Mechanisms of inhibition by melatonin, J Pineal Res. janv, vol.62, issue.1, 2017.

R. J. Reiter, Pineal gland interface between the photoperiodic environment and the endocrine system, Trends Endocrinol Metab TEM. févr, vol.2, issue.1, pp.13-22, 1991.

F. G. Revel, L. Ansel, P. Klosen, M. Saboureau, P. Pévet et al., Kisspeptin: a key link to seasonal breeding, Rev Endocr Metab Disord. mars, vol.8, issue.1, pp.57-65, 2007.

A. Régnier-loilier, Évolution de la saisonnalité des naissances en France de 1975 à nos jours, Population, vol.65, issue.1, p.147, 2010.

B. C. Voordouw, R. Euser, R. E. Verdonk, B. T. Alberda, F. H. De-jong et al., Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation, J Clin Endocrinol Metab. janv, vol.74, issue.1, pp.108-125, 1992.

A. Moayeri, T. Mokhtari, A. Hedayatpour, H. Abbaszadeh, S. Mohammadpour et al., Impact of melatonin supplementation in the rat spermatogenesis subjected to forced swimming exercise, Andrologia. avr, vol.50, issue.3, 2018.

M. B. Frungieri, R. S. Calandra, and S. P. Rossi, Local Actions of Melatonin in Somatic Cells of the Testis, Int J Mol Sci. 31 mai, vol.18, issue.6, 2017.

R. Garcia-marin, J. M. Fernandez-santos, J. Morillo-bernal, F. Gordillo-martinez, V. Vazquez-roman et al., Melatonin in the thyroid gland: regulation by thyroid-stimulating hormone and role in thyroglobulin gene expression, J Physiol Pharmacol Off J Pol Physiol Soc, vol.66, issue.5, pp.643-52, 2015.

Y. Touitou, Mélatonine : de la physiologie à la pathologie, EMC -Endocrinol -Nutr. 1 janv, vol.5, pp.1-7, 2008.

Y. Li, H. Wu, N. Liu, X. Cao, Z. Yang et al., Melatonin exerts an inhibitory effect on insulin gene transcription via MTNR1B and the downstream Raf-1/ERK signaling pathway, Int J Mol Med. févr, vol.41, issue.2, pp.955-61, 2018.

S. Sharma, H. Singh, N. Ahmad, P. Mishra, and A. Tiwari, The role of melatonin in diabetes: therapeutic implications, Arch Endocrinol Metab, vol.59, issue.5, pp.391-400, 2015.

. Circadin--eurekasanté-par and . Vidal,

. Eurekasanté,

D. Sur,

, ANSM rappelle le cadre réglementaire concernant la réalisation de préparations à base de mélatonine -Point d'Information -ANSM : Agence nationale de sécurité du médicament et des produits de santé

D. Sur,

B. Claustrat and . Melatonine, INDICATIONS THERAPEUTIQUES ET CONDITIONS DE PRESCRIPTION, vol.20, 2018.

. Anonymous and . Circadin,

, European Medicines Agency, 2018.

D. Sur,

K. Mundey, S. Benloucif, K. Harsanyi, M. L. Dubocovich, and P. C. Zee, Phase-dependent treatment of delayed sleep phase syndrome with melatonin. Sleep, vol.28, pp.1271-1279, 2005.

L. Kayumov, G. Brown, R. Jindal, K. Buttoo, and C. M. Shapiro, A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome, Psychosom Med. févr, vol.63, issue.1, pp.40-48, 2001.

J. E. Nagtegaal, G. A. Kerkhof, M. G. Smits, A. C. Swart, and Y. G. Van-der-meer, Delayed sleep phase syndrome: A placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset, J Sleep Res. juin, vol.7, issue.2, pp.135-178, 1998.

A. Oldani, L. Ferini-strambi, M. Zucconi, B. Stankov, F. Fraschini et al., Melatonin and delayed sleep phase syndrome: ambulatory polygraphic evaluation, Neuroreport. 30 déc, vol.6, issue.1, pp.132-136, 1994.

R. L. Sack, R. W. Brandes, A. R. Kendall, and A. J. Lewy, Entrainment of free-running circadian rhythms by melatonin in blind people, N Engl J Med, vol.343, issue.15, pp.1070-1077, 2000.

L. M. Hack, S. W. Lockley, J. Arendt, and D. J. Skene, The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects, J Biol Rhythms, vol.18, issue.5, pp.420-429, 2003.

A. J. Lewy, V. K. Bauer, B. P. Hasler, A. R. Kendall, M. L. Pires et al., Capturing the circadian rhythms of free-running blind people with 0.5 mg melatonin, Brain Res, vol.918, issue.1-2, pp.96-100, 2001.

A. J. Lewy, J. S. Emens, R. L. Sack, B. P. Hasler, and R. A. Bernert, Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period, Chronobiol Int. mai, vol.19, issue.3, pp.649-58, 2002.

V. Bayon and D. Léger,

, Rev Prat. mars, vol.64, issue.3, pp.363-371, 2014.

K. J. Reid and S. M. Abbott, Jet Lag and Shift Work Disorder, Sleep Med Clin. déc, vol.10, issue.4, pp.523-558, 2015.

S. Daugaard, A. H. Garde, J. Bonde, J. Christoffersen, Ä. M. Hansen et al., Night work, light exposure and melatonin on work days and days off, Chronobiol Int, vol.34, issue.7, pp.942-55, 2017.

J. Arendt, D. J. Skene, B. Middleton, S. W. Lockley, and S. Deacon, Efficacy of melatonin treatment in jet lag, shift work, and blindness, J Biol Rhythms. déc, vol.12, issue.6, pp.604-621, 1997.

J. Arendt and D. J. Skene, Melatonin as a chronobiotic, Sleep Med Rev. févr, vol.9, issue.1, pp.25-39, 2005.

J. Arendt and S. Deacon, Treatment of circadian rhythm disorders--melatonin, Chronobiol Int. mars, vol.14, issue.2, pp.185-204, 1997.

R. L. Sack and A. J. Lewy, Melatonin as a chronobiotic: treatment of circadian desynchrony in night workers and the blind, J Biol Rhythms. déc, vol.12, issue.6, pp.595-603, 1997.

M. R. Smith and C. I. Eastman, Shift work: health, performance and safety problems, traditional countermeasures, and innovative management strategies to reduce circadian misalignment, Nature and Science of Sleep, 2012.

R. L. Sack, D. Auckley, R. R. Auger, M. A. Carskadon, K. P. Wright et al., Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders, An American Academy of Sleep Medicine review. Sleep, vol.30, issue.11, pp.1460-83, 2007.

R. L. Sack, D. Auckley, R. R. Auger, M. A. Carskadon, K. P. Wright et al., Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm, An American Academy of Sleep Medicine review. Sleep, vol.30, issue.11, pp.1484-501, 2007.

B. Claustrat, J. Brun, M. David, G. Sassolas, and G. Chazot, Melatonin and jet lag: confirmatory result using a simplified protocol, Biol Psychiatry, vol.32, issue.8, pp.705-716, 1992.

J. Arendt, M. Aldhous, and V. Marks, Alleviation of jet lag by melatonin: preliminary results of controlled double blind trial, Br Med J Clin Res Ed. 3 mai, vol.292, issue.6529, p.1170, 1986.

K. Petrie, J. V. Conaglen, L. Thompson, and K. Chamberlain, Effect of melatonin on jet lag after long haul flights, BMJ. 18 mars, vol.298, issue.6675, pp.705-712, 1989.

N. Buscemi, B. Vandermeer, N. Hooton, R. Pandya, L. Tjosvold et al., Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis, BMJ. 18 févr, vol.332, issue.7538, pp.385-93, 2006.

R. L. Spitzer, M. Terman, J. B. Williams, J. S. Terman, U. F. Malt et al., Jet lag: clinical features, validation of a new syndrome-specific scale, and lack of response to melatonin in a randomized, double-blind trial, Am J Psychiatry. sept, vol.156, issue.9, pp.1392-1398, 1999.

F. Tortorolo, F. Farren, and G. Rada, Is melatonin useful for jet lag?, Medwave. 21 déc, vol.15, 2015.

S. Noyek, K. Yaremchuk, and B. Rotenberg, Does melatonin have a meaningful role as a sleep aid for jet lag recovery?, The Laryngoscope. 1 août, vol.126, issue.8, pp.1719-1739, 2016.

B. J. Edwards, G. Atkinson, J. Waterhouse, T. Reilly, R. Godfrey et al., Use of melatonin in recovery from jet-lag following an eastward flight across 10 time-zones, Ergonomics, vol.43, issue.10, pp.1501-1514, 2000.

I. Feinberg, R. L. Koresko, and N. Heller, EEG sleep patterns as a function of normal and pathological aging in man, J Psychiatr Res. juin, vol.5, issue.2, pp.107-151, 1967.

D. J. Dijk and J. F. Duffy, Circadian regulation of human sleep and age-related changes in its timing, consolidation and EEG characteristics, Ann Med. avr, vol.31, issue.2, pp.130-170, 1999.

D. J. Dijk, J. F. Duffy, E. Riel, T. L. Shanahan, and C. A. Czeisler, Ageing and the circadian and homeostatic regulation of human sleep during forced desynchrony of rest, melatonin and temperature rhythms, J Physiol. 15 avr, vol.516, issue.2, pp.611-638, 1999.

M. Munch, V. Knoblauch, K. Blatter, A. Wirz-justice, and C. Cajochen, Is homeostatic sleep regulation under low sleep pressure modified by age?, Sleep. juin, vol.30, issue.6, pp.781-92, 2007.

D. Leger, M. Laudon, and N. Zisapel, Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy, Am J Med. 15 janv, vol.116, issue.2, pp.91-96, 2004.

R. J. Wurtman and I. Zhdanova, Improvement of sleep quality by melatonin, Lancet Lond Engl. 2 déc, vol.346, issue.8988, p.1491, 1995.

L. Lamberg, Melatonin potentially useful but safety, efficacy remain uncertain, JAMA, vol.276, issue.13, pp.1011-1015, 1996.

M. Vecchierini,

, Psychol Neuropsychiatr Vieil. mars, vol.8, issue.1, pp.15-23, 2010.

J. Xu, L. Wang, E. B. Dammer, C. Li, G. Xu et al., Melatonin for sleep disorders and cognition in dementia: a meta-analysis of randomized controlled trials, Am J Alzheimers Dis Other Demen. août, vol.30, issue.5, pp.439-486, 2015.

Y. Wang, W. Zheng, C. H. Ng, G. S. Ungvari, W. Wei et al., Meta-analysis of randomized, double-blind, placebo-controlled trials of melatonin in Alzheimer's disease, Int J Geriatr Psychiatry, vol.32, issue.1, pp.50-57, 2017.

C. Singer, R. E. Tractenberg, J. Kaye, K. Schafer, A. Gamst et al., A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease, Sleep, vol.26, issue.7, pp.893-901, 2003.

M. Serfaty, S. Kennell-webb, J. Warner, R. Blizard, and P. Raven, Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia, Int J Geriatr Psychiatry. déc, vol.17, issue.12, pp.1120-1127, 2002.

R. F. Riemersma-van-der-lek, D. F. Swaab, J. Twisk, E. M. Hol, W. Hoogendijk et al., Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial, JAMA. 11 juin, vol.299, issue.22, pp.2642-55, 2008.

C. Medeiros, C. De-bruin, P. F. Lopes, L. A. Magalhães, M. C. De et al., Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study, J Neurol. avr, vol.254, issue.4, pp.459-64, 2007.

G. A. Dowling, J. Mastick, E. Colling, J. H. Carter, C. M. Singer et al., Melatonin for sleep disturbances in Parkinson's disease, Sleep Med. sept, vol.6, issue.5, pp.459-66, 2005.

, Etude Mélatonine -résultat

. Sfrms, Disponible sur

S. Kemp, R. Biswas, V. Neumann, and A. Coughlan, The value of melatonin for sleep disorders occurring post-head injury: a pilot RCT, Brain Inj. sept, vol.18, issue.9, pp.911-920, 2004.

C. W. Bazil, D. Short, D. Crispin, and W. Zheng, Patients with intractable epilepsy have low melatonin, which increases following seizures, Neurology. 12 déc, vol.55, issue.11, pp.1746-1754, 2000.

F. Brigo, S. C. Igwe, D. Felice, and A. , Melatonin as add-on treatment for epilepsy, Cochrane Database Syst Rev. 11 août, issue.8, p.6967, 2016.

S. Jain and F. Besag, Does melatonin affect epileptic seizures?, Drug Saf. avr, vol.36, issue.4, pp.207-222, 2013.

A. L. Gonçalves, M. Ferreira, A. Ribeiro, R. T. Zukerman, E. Cipolla-neto et al., Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention, J Neurol Neurosurg Psychiatry, vol.87, issue.10, pp.1127-1159, 2016.

M. V. Hansen, A. K. Danielsen, I. Hageman, J. Rosenberg, and I. Gögenur, The therapeutic or prophylactic effect of exogenous melatonin against depression and depressive symptoms: a systematic review and meta-analysis, Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. nov, vol.24, issue.11, pp.1719-1747, 2014.

L. Shamseer, S. Vohra, . Complementary, I. Holistic, and . Medicine, Melatonin. Pediatr Rev. 1 juin, vol.30, issue.6, pp.223-231, 2009.

G. M. Tibbitts, Sleep disorders: causes, effects, and solutions, Prim Care. déc, vol.35, issue.4, pp.817-854, 2008.

D. C. Lin-dyken and M. E. Dyken, Use of Melatonin in Young Children for Sleep Disorders, Infants Young Child, vol.15, issue.2, p.20, 2002.

M. K. Lebourgeois, L. Hale, A. Chang, L. D. Akacem, H. E. Montgomery-downs et al., Digital Media and Sleep in Childhood and Adolescence. Pediatrics, vol.140, pp.92-98, 2017.

S. Babineau, C. Goodwin, and B. Walker, FPIN's clinical inquiries. Medications for insomnia treatment in children, Am Fam Physician. 1 févr, vol.77, issue.3, pp.358-367, 2008.

I. M. Van-geijlswijk, K. B. Van-der-heijden, A. Egberts, H. Korzilius, and M. G. Smits, Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT. Psychopharmacology (Berl), vol.212, pp.379-91, 2010.

I. M. Van-geijlswijk, R. H. Mol, T. Egberts, and M. G. Smits, Evaluation of sleep, puberty and mental health in children with long-term melatonin treatment for chronic idiopathic childhood sleep onset insomnia, Psychopharmacology (Berl). juill, vol.216, issue.1, pp.111-131, 2011.

T. C. Zwart, M. G. Smits, T. Egberts, C. Rademaker, and I. M. Van-geijlswijk, Long-Term Melatonin Therapy for Adolescents and Young Adults with Chronic Sleep Onset Insomnia and Late Melatonin Onset: Evaluation of Sleep Quality, Chronotype, and Lifestyle Factors Compared to Age-Related Randomly Selected Population Cohorts, Healthc Basel Switz. 2 mars, vol.6, issue.1, 2018.

M. G. Smits, E. E. Nagtegaal, J. Van-der-heijden, A. M. Coenen, and G. A. Kerkhof, Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial, J Child Neurol. févr, vol.16, issue.2, pp.86-92, 2001.

A. Van-maanen, A. M. Meijer, M. G. Smits, K. B. Van-der-heijden, and F. J. Oort, Effects of Melatonin and Bright Light Treatment in Childhood Chronic Sleep Onset Insomnia With Late Melatonin Onset: A Randomized Controlled Study, Sleep. 1 févr, vol.40, issue.2, 2017.

M. G. Smits, H. F. Van-stel, K. Van-der-heijden, A. M. Meijer, A. Coenen et al., Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial. J Am Acad Child Adolesc Psychiatry, vol.42, pp.1286-93, 2003.

, SFRMS, vol.3, 2017.

M. D. Weiss, M. B. Wasdell, M. M. Bomben, K. J. Rea, and R. D. Freeman, Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia, J Am Acad Child Adolesc Psychiatry. mai, vol.45, issue.5, pp.512-521, 2006.

K. B. Van-der-heijden, M. G. Smits, E. Van-someren, K. R. Ridderinkhof, and W. B. Gunning, Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia, J Am Acad Child Adolesc Psychiatry. févr, vol.46, issue.2, pp.233-274, 2007.

M. Hoebert, K. B. Van-der-heijden, I. M. Van-geijlswijk, and M. G. Smits, Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia, J Pineal Res. août, vol.47, issue.1, pp.1-7, 2009.

D. A. Rossignol and R. E. Frye, Melatonin in autism spectrum disorders, Curr Clin Pharmacol, vol.9, issue.4, pp.326-360, 2014.

I. M. Andersen, J. Kaczmarska, S. G. Mcgrew, and B. A. Malow, Melatonin for insomnia in children with autism spectrum disorders, J Child Neurol. mai, vol.23, issue.5, pp.482-487, 2008.

J. Garstang and M. Wallis, Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev, vol.32, pp.585-594, 2006.

B. Wright, D. Sims, S. Smart, A. Alwazeer, B. Alderson-day et al., Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial, J Autism Dev Disord. févr, vol.41, issue.2, pp.175-84, 2011.

D. A. Rossignol and R. E. Frye, Melatonin in autism spectrum disorders: a systematic review and meta-analysis, Dev Med Child Neurol. sept, vol.53, issue.9, pp.783-92, 2011.

O. D. Howes, M. Rogdaki, J. L. Findon, R. H. Wichers, T. Charman et al., Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology, J Psychopharmacol Oxf Engl, vol.32, issue.1, pp.3-29, 2018.

W. Braam, R. Didden, M. G. Smits, and L. Curfs, Melatonin for chronic insomnia in Angelman syndrome: a randomized placebo-controlled trial, J Child Neurol. juin, vol.23, issue.6, pp.649-54, 2008.

W. Braam, R. Didden, A. Maas, H. Korzilius, M. G. Smits et al., Melatonin decreases daytime challenging behaviour in persons with intellectual disability and chronic insomnia, J Intellect Disabil Res JIDR. 1 janv, vol.54, issue.1, pp.52-61, 2010.

K. Spruyt, W. Braam, M. Smits, and L. M. Curfs, Sleep Complaints and the 24-h Melatonin Level in Individuals with Smith-Magenis Syndrome: Assessment for Effective Intervention, CNS Neurosci Ther, vol.22, issue.11, pp.928-963, 2016.

D. Leersnyder and H. , Smith-Magenis syndrome, Handb Clin Neurol, vol.111, pp.295-301, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02104184

H. De-leersnyder, N. Zisapel, and M. Laudon, Prolonged-release melatonin for children with neurodevelopmental disorders, Pediatr Neurol. juill, vol.45, issue.1, pp.23-29, 2011.

J. E. Jan, D. Hamilton, N. Seward, D. K. Fast, R. D. Freeman et al., Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders, J Pineal Res. août, vol.29, issue.1, pp.34-43, 2000.

R. Carr, M. B. Wasdell, D. Hamilton, M. D. Weiss, R. D. Freeman et al., Long-term effectiveness outcome of melatonin therapy in children with treatment-resistant circadian rhythm sleep disorders, J Pineal Res, vol.43, issue.4, pp.351-360, 2007.

M. B. Wasdell, J. E. Jan, M. M. Bomben, R. D. Freeman, W. J. Rietveld et al., A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities, J Pineal Res. janv, vol.44, issue.1, pp.57-64, 2008.

, Avis de l'Anses Mélatonine Saisine n° 2016-SA-0209

N. Buscemi, B. Vandermeer, N. Hooton, R. Pandya, L. Tjosvold et al., The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis, J Gen Intern Med. déc, vol.20, issue.12, pp.1151-1159, 2005.

N. Buscemi, B. Vandermeer, N. Hooton, R. Pandya, L. Tjosvold et al., Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis, BMJ. 18 févr, vol.332, issue.7538, pp.385-93, 2006.

N. Buscemi, B. Vandermeer, C. Friesen, L. Bialy, M. Tubman et al., The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs, J Gen Intern Med. sept, vol.22, issue.9, pp.1335-50, 2007.

M. L. Seabra, M. Bignotto, L. R. Pinto, and S. Tufik, Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment, J Pineal Res, vol.29, issue.4, pp.193-200, 2000.

I. M. Van-geijlswijk, H. Korzilius, and M. G. Smits, The Use of Exogenous Melatonin in Delayed Sleep Phase Disorder: A Meta-analysis, Sleep. 1 déc, vol.33, issue.12, pp.1605-1619, 2010.

R. B. Costello, C. V. Lentino, C. C. Boyd, M. L. O'connell, C. C. Crawford et al., The effectiveness of melatonin for promoting healthy sleep: a rapid evidence assessment of the literature, Nutr J, vol.13, p.106, 2014.

W. Y. Chen, A. Giobbie-hurder, K. Gantman, J. Savoie, R. Scheib et al., A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes, Breast Cancer Res Treat. juin, vol.145, issue.2, pp.381-389, 2014.

R. Fallah, F. F. Shoroki, and F. Ferdosian, Safety and efficacy of melatonin in pediatric migraine prophylaxis, Curr Drug Saf, vol.10, issue.2, pp.132-137, 2015.

C. Cajochen, K. Kräuchi, M. A. Von-arx, D. Möri, P. Graw et al., Daytime melatonin administration enhances sleepiness and theta/alpha activity in the waking EEG, Neurosci Lett. 5 avr, vol.207, issue.3, pp.209-222, 1996.

A. Suhner, P. Schlagenhauf, A. Tschopp, R. Hauri-bionda, A. Friedrich-koch et al., Impact of melatonin on driving performance, J Travel Med. mars, vol.5, issue.1, pp.7-13, 1998.

S. H. Sheldon, Pro-convulsant effects of oral melatonin in neurologically disabled children, Lancet Lond Engl. 25 avr, vol.351, issue.9111, p.1254, 1998.

B. Guardiola-lemaître, Toxicology of melatonin, J Biol Rhythms. déc, vol.12, issue.6, pp.697-706, 1997.

R. F. Riemersma-van-der-lek, D. F. Swaab, J. Twisk, E. M. Hol, W. Hoogendijk et al., Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial, JAMA. 11 juin, vol.299, issue.22, pp.2642-55, 2008.

P. Gringras, C. Gamble, A. P. Jones, L. Wiggs, P. R. Williamson et al., Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial, BMJ, vol.345, p.6664, 2012.

C. Richings, Case series: Melatonin induced agitation in three patients with intellectual disability, Br J Dev Disabil, p.55, 2010.

W. Braam, R. Didden, M. Smits, and L. Curfs, Melatonin treatment in individuals with intellectual disability and chronic insomnia: a randomized placebo-controlled study, J Intellect Disabil Res JIDR. mars, vol.52, pp.256-64, 2008.

J. R. Calvo, J. M. Guerrero, C. Osuna, P. Molinero, and A. Carrillo-vico, Melatonin triggers Crohn's disease symptoms, J Pineal Res. mai, vol.32, issue.4, pp.277-285, 2002.

M. D. Maldonado and J. R. Calvo, Melatonin usage in ulcerative colitis: a case report, J Pineal Res, vol.45, issue.3, pp.339-379, 2008.

Y. G. Hong and J. L. Riegler, Is melatonin associated with the development of autoimmune hepatitis?, J Clin Gastroenterol. juill, vol.25, issue.1, pp.376-384, 1997.

L. T. Fourman, R. Meyer, and B. , Autoimmune hepatitis in association with ramelteon, J Clin Gastroenterol. août, vol.47, issue.7, pp.651-655, 2013.

G. Lin, S. Huang, S. Chen, C. Wang, C. Sytwu et al., Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases, Int J Mol Sci. 31 mai, vol.14, issue.6, pp.11742-66, 2013.

A. Sulli, G. Maestroni, B. Villaggio, E. Hertens, C. Craviotto et al., Melatonin serum levels in rheumatoid arthritis, Ann N Y Acad Sci. juin, vol.966, pp.276-83, 2002.

D. Sur,

R. J. Reiter, S. A. Rosales-corral, D. Tan, D. Acuna-castroviejo, L. Qin et al.,

. Melatonin, Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis, Int J Mol Sci. 17 avr, vol.18, issue.4, 2017.

A. González-gonzález, M. D. Mediavilla, and E. J. Sánchez-barceló, Melatonin: A Molecule for Reducing Breast Cancer Risk, Mol Basel Switz. 6 févr, vol.23, issue.2, 2018.

M. Frisher, N. Gibbons, J. Bashford, S. Chapman, and W. S. Melatonin, hypnotics and their association with fracture: a matched cohort study, Age Ageing, vol.45, issue.6, pp.801-807, 2016.

R. Stoianovici, L. Brunetti, and C. D. Adams, Comparison of Melatonin and Zolpidem for Sleep in an Academic Community Hospital: An Analysis of Patient Perception and Inpatient Outcomes, J Pharm Pract. 25 juin, 2019.

J. W. Stewart and U. Halbreich, Plasma melatonin levels in depressed patients before and after treatment with antidepressant medication, Biol Psychiatry. janv, vol.25, issue.1, pp.33-41, 1989.

Y. Ergün, F. O. Orhan, and M. F. Karaaslan, Combination therapy of imipramine and melatonin: additive antidepressant effect in mouse forced swimming test, Eur J Pharmacol. 4 sept, vol.591, issue.1-3, pp.159-63, 2008.

D. Léger, J. Paquereau, B. Claustrat, S. Royant-parola, I. Poirot et al., Sommeil normal et rythme veille-sommeil. 2013;20. 255. melatonine_cpam-hauts-de-seine

, le présent travail s'attache aux insomnies proprement dites de l'adulte, telles que classées par l'ICSD-2 et qui répondent aux critères généraux de l'insomnie

, Encadré 1. Critères généraux de l'insomnie selon l'ICSD-2

A. , Le patient rapporte un ou plusieurs des plaintes suivantes : 1. difficulté à s'endormir 2. difficulté à rester endormi 3. réveil trop précoce 4. sommeil durablement non réparateur ou de mauvaise qualité B. Les difficultés ci-dessus surviennent en dépit d'opportunités et de circonstances adéquates pour dormir

, Au moins un des symptômes suivants relatif au problème du sommeil nocturne est rapporté par le patient : 1. fatigue, méforme 2. baisse d'attention, de concentration ou de mémoire 3. dysfonctionnement social, professionnel ou mauvaise performance scolaire 4. instabilité d'humeur, irritabilité 5. somnolence diurne 6. baisse de motivation

, « Par délibération de son Conseil en date du 10 Novembre 1972, l'Université n'entend donner aucune approbation ni improbation aux opinions émises dans les thèses ou mémoires. Ces opinions doivent être considérées comme propres à leurs auteurs